Finally, KEGG analysis revealed that the active ingredients of QHD affected NAFLD, involving cancer pathways, P13K-AKT signaling pathway, PPAR signaling pathway, cAMP signaling pathway, HIF-1 signaling pathway, HTLV-1 infection, and other pathways. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.